Related Experiment Videos
Effect of digoxin on the heart in normal subjects: influence of isometric exercise and autonomic blockade: a
J Partanen1, J Heikkilä, T Pellinen
1Cardiovascular Laboratory, University Central Hospital, Helsinki, Finland.
Insights
Digoxin enhances heart contractility in healthy individuals, improving fractional shortening and decreasing electromechanic systolic time index (QS2I) in a dose-dependent manner. These positive inotropic effects occur both at rest and during exercise, even without autonomic support.
Area of Science:
- Cardiology
- Pharmacology
- Physiology
Background:
- Digoxin is a cardiac glycoside used to treat heart failure and arrhythmias.
- Its effects on myocardial contractility and autonomic function in healthy individuals require further elucidation.
Purpose of the Study:
- To investigate the dose-dependent effects of digoxin on cardiac function and heart rate in healthy subjects.
- To assess the influence of digoxin on cardiac performance during autonomic blockade and isometric exercise.
Main Methods:
- Eight healthy subjects received escalating doses of digoxin (0.125, 0.25, 0.50 mg/day).
- Cardiac function was evaluated using echocardiography and systolic time intervals at rest and during handgrip exercise.
- Autonomic blockade was induced using atropine and propranolol.
Main Results:
- Digoxin dose-dependently decreased resting heart rate and increased fractional shortening (a measure of contractility).
- The electromechanic systolic time index (QS2I) significantly decreased, indicating improved systolic function.
- During autonomic blockade and handgrip exercise, digoxin still enhanced contractility, suggesting direct myocardial effects.
Conclusions:
- Digoxin increases myocardial contractility in healthy hearts without altering preload or afterload.
- The positive inotropic effects of digoxin are evident at rest and during stress, independent of autonomic nervous system mediation.
- Digoxin's influence on heart rate and contractility is dose-dependent and partly mediated directly on the heart muscle.
Abstract:
1. Eight healthy subjects were studied before digoxin and after successive therapy periods of 1 week 0.125, 0.25 and 0.50 mg of digoxin. The mean serum concentrations (+/- s. d.) were 0.4 +/- 0.2, 0.6 +/- 0.3 and 1.4 +/- 0.5 nmol l-1, respectively. The effects of digitalis were studied by echocardiography and systolic time intervals at rest and after 3 min handgrip exercise. Effects of simultaneous autonomic blockade induced by atropine and propranolol were also examined. 2. Digoxin in increasing doses slowed the heart rate at rest; with the daily dose of 0.50 mg from 63 +/- 10 to 53 +/- 6 beats min-1, and fractional shortening rose from 28 +/- 6 to 33 +/- 3% (P less than 0.05 for both). Preload, afterload and cardiac output did not change. The electromechanic systolic time index (QS2I) decreased (P less than 0.001) and the observed alteration of QS2I was dose-related. 3. The influence of digoxin was similar during isometric exercise, except for unchanged fractional shortening. 4. During autonomic blockade digoxin slowed the intrinsic heart rate from 93 +/- 6 to 86 +/- 6 beats min-1 (0.25 mg) and to 83 +/- 6 beats min-1 (0.50 mg) (P less than 0.01 for both). QS2I was shortened (P less than 0.01). Echocardiographically determined ejection phase indices remained unchanged. 5. When handgrip stress was induced during autonomic blockade, digoxin evoked a clearcut increase in contractile function, resembling the effects of digoxin alone at rest. Thus, fractional shortening increased by 14% and QS2I decreased by 16 ms (P less than 0.01 for both). 6. We conclude that digoxin increases the contractility in normal heart without changes in loading conditions. The rise in inotropy at rest is obvious from both fractional shortening by echo and systolic time intervals. The same takes place during handgrip with autonomic blockade, when the heart lacks sympathetic support. The influence of long-term digoxin on heart rate is partly direct without autonomic mediation. The effect of digoxin is dose-dependent.